<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2803233433
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        UNIPROST 4 MG TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DOXAZOSIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.9
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BATTERJEE PHARMACETICAL FACTORY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 651]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACEUTICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C02CA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Uniprost&reg;belongs to the group known as vasodilators. These substances cause the blood vessel to widen, which reduces the blood pressure.</p><p>UNIPROST&reg;can also reduce tension in the muscle tissues of the prostate and the urinary tract.</p><p>Uniprost&reg;is used to treat:</p><p>- high blood pressure;- symptoms of an enlarged prostate.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take</p><p>- If you are allergic (hypersensitive) to doxazosin, other medicines from the same group (known asquinazolines, such as e.g. prazosin and terazosin) or any of the other ingredients of Uniprost&reg;.</p><p>- If you have a history of a condition known as &#39;orthostatic hypotension&#39; which is a form of low blood pressure that causes you to feel dizzy or lightheaded when you stand up from sitting or lying down.</p><p>- If you have an enlarged prostate gland with one of the following: any kind of congestion or blockage in your urinary tract, a longstanding infection of the urinary tract or you have bladder stones.</p><p>- If you are breastfeeding.</p><p>- If you have an enlarged prostate gland (benign prostatic hyperplasia) and have low blood pressure.</p><p>- If you have overflow incontinence (you do not feel the urge to urinate), or anuria (your body is not producing any urine) with or without kidney problems.</p><p>&nbsp;</p><p>Tell your doctor before you start to take this medicine if you:</p><p>Suffer from serious heart problems such as e.g. severely reduced cardiac function or a restrictive and painful sensation in the chest (angina pectoris);</p><p>- Are on a strict low salt diet;- Are using diuretics;</p><p>- Have kidney or liver problems.</p><p>If you are undergoing eye surgery because of cataract (cloudiness of the lens) please inform your eye specialist before the operation that you are using or have previously used Uniprost&reg;. This is because UNIPROST&reg; may cause complications during the surgery which can be managed if your specialist is prepared in advance.</p><p>&nbsp;</p><p>Using other medicines</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>- Some patients who take alpha blocker therapy for the treatment of high blood pressure or prostate enlargement may experience dizziness or lightheadedness, which may be caused by low blood pressure upon sitting or standing up quickly. Certain patients have experienced these symptoms when taking drugs for erectile dysfunction (impotence) with alpha blockers. In order to reduce the likelihood that these symptoms occur, you should be on a regular daily dose of your alpha blocker before you start drugs for erectile dysfunction.</p><p>- Uniprost&reg; may lower your blood pressure even more if you are already taking other medicines to treat high blood pressure such as terazosin and prazosin.</p><p>- Nitrates (medicines for heart problems) such as nitroglycerine and isosorbide nitrate: these can exacerbate the hypotensive effect.</p><p>- Certain painkillers for rheumatism (known as non-steroidal anti-inflammatory drugs) such as naproxen, ibuprofen or any other anti-inflamatory painkiller: these can reduce the hypotensive effect.- Medications that could also possibly affect the liver metabolism. e.g. cimetidine (a medicine for stomach problems).</p><p>&nbsp;</p><p>Pregnancy and breast-feeding</p><p>If you are pregnant or think you might be pregnant you should contact your doctor before taking Uniprost&reg;.Uniprost&reg; should only be used during pregnancy if your doctor decides that the benefits for the mother outweigh the possible risk for the foetus</p><p>.Do not breast feed while taking Uniprost&reg;.</p><p>&nbsp;</p><p>Driving and using machinesUniprost&reg; can sometimes cause dizziness or fainting. In such an event, you should exercise care during activities that require attentiveness, such as driving, operating machinery and working at heights. If you are unsure whether Uniprost&reg; is having a negative effect on your ability to drive, discuss this with your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Uniprost&reg; exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>The usual dose is:</p><p>HIGH BLOOD PRESSURE: The initial dose is 1mg daily (= 24 hours) in a single dose. After 1 to 2 weeks, the dose is generally increased to 2mg in a single daily dose (= 24 hours). This dose is also retained for 1 to 2 weeks. If necessary, the dosage can be further increased to 4, 8 or 16mg per day, until the desired reduction in blood pressure is achieved. The maximum daily dose is 16mg.An initial dose should preferably be taken before going to bed; this means that any dizziness you may experience is less of a problem.</p><p>&nbsp;</p><p>ENLARGED PROSTATE: The initial dose is 1mg daily (= 24 hours) in a single dose. After this the usual dose is 2mg or 4mg daily. In some circumstances this may be increased to a maximum of 8mg daily.The tablets should be taken as a single dose each day (= 24 hours). The tablets must be taken with plenty of water.</p><p>&nbsp;</p><p>If you take more Uniprost&reg; than you should</p><p>If you have taken more than the prescribed dose, you should consult your doctor and/or pharmacist immediately. If you feel extremely dizzy or think you might faint, you should lie down immediately with your head down.</p><p>&nbsp;</p><p>If you forget to take Uniprost&reg;</p><p>If you have forgotten to take a tablet, then skip it and take the next tablet at the usual time. You should check with your doctor or pharmacist if you are unsure. Do not take a double dose to make up for a forgotten tablet.</p><p>&nbsp;</p><p>If you stop taking Uniprost&reg;</p><p>If you suddenly stop taking Uniprost&reg;, the complaints you suffered prior to the start of treatment may recur. It is therefore better not to stop taking this medication suddenly. Your doctor will decrease the dosage gradually. You should always check with your doctor or pharmacist if you are unsure.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Doxazosin can cause side effects, although not everybody gets them. Some side effects could be serious:</p><p>If any of the following happens, stop taking this medicine and tell your doctor immediately or go to the casualty department at your nearest hospital:</p><p>- Allergic reactions such as wheezing, shortness of breath, extreme dizziness or collapse, swelling of the face or throat, or a serious skin rash with red spots or blisters.</p><p>- Chest pain, increased or irregular heartbeat, heart attack or stroke.</p><p>- Yellowing of the skin or whites of the eyes, caused by liver problems.</p><p>- Unusual bruising or bleeding caused by low blood platelets.</p><p>These side effects are uncommon (affects 1 to 10 users in 1 ,000) or rare (affects 1 to 10 users in 10,000)</p><p>&nbsp;</p><p>Other side effects:</p><p>Very common (affects more than 1 users in 10)- Dizziness, headache.Common (affects 1 to 10 users in 100):- Respiratory tract infection, inflammation of the air passages within the lungs, cough, shortage of breath, nasal stuffiness and/or runny nose.- Urinary tract infection, urinary incontinence (inability to control passing urine).</p><p>- Loss of appetite.</p><p>- Anxiety, sleeplessness (insomnia), nervousness.</p><p>- Dizziness, tingling or numbness of the hands and feet (paraesthesia), sleepiness (somnolence).</p><p>- Feeling of dizziness or &quot;spinning&quot; (vertigo).</p><p>- Feeling or sensation of irregular heartbeat (palpitation), increased heart rate.</p><p>- Low blood pressure and low blood pressure as a result of getting up from a sitting or lying position (postural hypotension).</p><p>- Abdominal pain, indigestion, dry mouth, feeling sick (nausea), diarrhoea itching (pruritus).- Back pain, muscle pain (myalgia).</p><p>- Inflammation of the bladder (cystitis).</p><p>- Feeling of weakness (asthenia), chest pain, influenza like symptoms.</p><p>- Welling of the ankles, feet or fingers (peripheral oedema), feeling tired (fatigue), malaise.</p><p>&nbsp;</p><p>Uncommon (affects 1 to 10 users in 1,000):</p><p>- Allergic drug reaction.</p><p>- Gout, increased appetite.</p><p>- Agitation, depression.</p><p>- Stroke, reduced sense of touch or sensation, fainting.</p><p>- Ringing or noise in the ears (tinnitus).</p><p>- Chest pain (angina pectoris), heart attack (myocardial infarction), irregular heartbeat.</p><p>- Flushing.</p><p>- Nosebleed, cough.</p><p>- Constipation, flatulence, vomiting (being sick), inflammation of the gastrointesti-nal tract.</p><p>- Abnormal liver function test.</p><p>- Skin rash, hair loss (alopecia), rash caused by bleeding under the skin (purpura)-</p><p>- Joint pain, muscle cramps, muscle weakness.</p><p>- Painful or difficult urination, presence of red blood cells in the urine (hematuria), urinary incontinence (inability to control passing urine).</p><p>- Difficulty to develop an erection (impotence).</p><p>- Pain, swelling of the face.</p><p>- Weight increase.Very Rare (affects less than 1 user in 10,000):</p><p>- Reduced numbers of blood platelets.- Reduced number of white and red blood cells.</p><p>- Blurred vision.</p><p>- Reduced heart rate.</p><p>- Bronchial spasm.</p><p>- Blocked flow of bile (cholestasis), inflammation of the liver (hepatitis).</p><p>- Yellowing of the skin or whites of the eyes caused by liver or blood problems (jaundice).</p><p>- Abnormal liver function tests.</p><p>- Increased blood levels of urea and creatin.</p><p>- Obstruction to the normal flow of bile (cholestatis) which may cause jaundice (yellowing of the skin or whites of the eyes).</p><p>- Inflammation of the liver (hepatitis).</p><p>- Hives (urticaria).</p><p>- Disorder in passing urine, needing to pass urine at night, increased volume of urine passed.</p><p>- Temporary enlargement of the breasts (gynaecomastia), painful persistent erection.</p><p>&nbsp;</p><p>Not known (frequency cannot be estimated from available data):- Eye problems may occur during eye surgery for cataract (cloudiness of the lens of the eye). See section &quot;Take special care with Doxazosin&quot;.</p><p>- Taste disturbances.</p><p>- Little or no semen ejaculated at sexual climax, cloudy urine following sexual climax (retrograde ejaculation).</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Store at temperature not exceeding 30 &deg;C.</p><p>- Keep out of the reach of children.- Do not use Uniprost&reg; Tabletsafter the expiry date (EXP) which is stated on the box and blister. The expiry date refers to the last day of that month.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is: Doxazosin. Each cross scored tablets contains 4 mg Doxazosin (as mesylate).The other ingredients are: Lactose monohydrate, Povidone, Polysorbate 80, Magnesium stearate,Microcrystalline cellulose, Colloidal silicon dioxide, Sodium starch glycolate, Isopropyl alcohol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Uniprost® Tablets are white round biconvex uncoated tablets.
Uniprost® Tablets is presented in a carton box containing 20 tablets in blisters along with a patient information leaflet.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>BATTERJEE PHARMA</p><p>Street No.: 401, Road No.: 403,</p><p>Industrial Area-Phase-IV,</p><p>P.O. Box: 10667,</p><p>Jeddah-21443,</p><p>Kingdom of Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2104
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;أقراص وفیما یستخدم۱ ملجم دوكسازوسین (على ھیئة میسیلات).</p><p>یحتوي كل قرص محزز من یونیبروست&reg; على 4 ملجم دوكسازوسین&nbsp;ینتمي إلى مجموعة تعرف بإسم موسعات الأوعیة. ھذه المواد تسبب إتساع الأوعیة على تخفیف حدة التوتر في الأنسجة ًالدمویة، مما یقلل من ضغط الدم. دوكسازوسین یعمل أیضاالعضلیة في البروستاتا والمسالك البولیة.یوصف یونیبروست&reg; أقراص في :</p><p>- ضغط دم مرتفع.</p><p>- أعراض تضخم البروستاتا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول یونیبروست&reg; أقراص:- إذا كنت تعاني من فرط الحساسیة لدوكسازوسین والأدویة الأخرى من نفس المجموعة )المعروفة بإسم كینازولین، مثل برازوسین وتیرازوسین( أو أي من المكونات الأخرى من یونیبروست&reg;.</p><p>- إذا كان لدیك تاریخ مرضي من حالة تعرف بإسم &quot;إنخفاض ضغط الدم الوضعي&quot; والذي ھو نوع من أنواع إنخفاض ضغط الدم الذي یسبب لك الشعور بالدوار أو بدوار عند الوقوف من الجلوس أو عند الإستلقاء. أي نوع من إحتقان إذا كنت تعاني من تضخم في غدة البروستاتا مع أحد الأعراض التالیة:</p><p>-أو إنسداد في المسالك البولیة، عدوى منذ فترة طویلة في المسالك البولیة أو لدیك حصى فى المثانة.</p><p>- إذا كنتي مرضعة.</p><p>- إذا كنت تعاني من التضخم الحمید لغده البروستاتا مع إنخفاض ضغط الدم.</p><p>- إذا كنت تعاني من سلس البول الفیضي )أنت لا تشعر بالحاجة إلى التبول(، أو إنقطاع البول )جسمك لا ینتج أي بول( مع أو بدون مشاكل في الكلى.</p><p>&nbsp;</p><p>&nbsp;</p><p>إخبر طبیبك قبل أن تبدأ تناول ھذا الدواء إذا كنت:</p><p>- تعاني من مشاكل خطیرة في القلب مثل إنخفاض شدید في وظائف القلب أو الإحساس بالضیق والألم في الصدر )الذبحة الصدریة(.</p><p>- تتبع نظام غذائي صارم منخفض الملح.</p><p>- تستخدم مدرات البول.</p><p>- لدیك مشكلة فى الكلى أو الكبد.إذا كنت ستجري جراحة فى العین بسبب إعتام عدسة العین )غیوم على العدسة( یرجى إبلاغ طبیب العیون الخاص بك قبل العملیة أنك تستخدم أو إستخدمت یونیبروست&reg; في السابق. وذلك لأن یونیبروست&reg; قد یسبب مضاعفات أثناء الجراحة التي یمكن السیطرة علیھا إذا كان الطبیب معد لذلك.ًمسبقا</p><p>&nbsp;</p><p>أخبر الطبیب أو الصیدلي إذا كنت تتناول أو تناولت مؤخرا&nbsp;أي أدویة أخرى، بما في ذلك الأدویة ًالتي تصرف بدون وصفة طبیة.</p><p>- بعض المرضى الذین یتناولون علاج )حاصرات مستقبلات الألفا( لعلاج إرتفاع ضغط الدم أو تضخم البروستاتا قد یعانون من الدوخة أو الدوار، والتي قد تكون ناجمة عن إنخفاض ضغط الدم عند الجلوس أو الوقوف بسرعة. عانى بعض المرضى من ھذه الأعراض عند تناول أدویة لعلاج ضعف الإنتصاب )الضعف الجنسي( مع حاصرات مستقبلات الألفا. من أجل الحد من إحتمالیة حدوث ھذه الأعراض، یجب أن تكون منتظم على الجرعة الیومیة العادیة لحاصرات مستقبلات الألفا قبل أن تبدأ تناول أدویة ضعف الإنتصاب.</p><p>- یونیبروست&reg; قد یسبب خفض ضغط الدم لدیك أكثر إذا كنت تأخذ بالفعل أدویة أخرى لعلاج إرتفاع ضغط الدم مثل تیرازوسین وبرازوسین.- النترات )أدویة لعلاج مشاكل في القلب( مثل النیتروجلسرین وإیزوسوربید نترات یمكن أن تؤدي إلى تفاقم التأثیر الخافض للضغط.</p><p>- بعض المسكنات للروماتیزم |)المعروفة باسم العقاقیر غیر الستیرویدیة المضادة للإلتھابات( مثل نابروكسین، إیبوبروفین أو أي مسكن آخر مضاد للإلتھاب یمكن أن یقلل من التأثیر الخافض للضغط. أن تؤثر على الأیض في الكبد. مثلا سیمیتیدین )دواء لعلاج ً</p><p>- الأدویة التي یحتمل أیضامشاكل في المعدة(.</p><p>&nbsp;</p><p>الحمل والرضاعة الطبیعیة</p><p>إذا كنتي حامل أو تعتقدین أنك قد تكوني حامل یجب علیكي الإتصال بطبیبك قبل تناول یونیبروست&reg;. ینبغي استخدام یونیبروست&reg; فقط أثناء فترة الحمل إذا قرر الطبیب أن الفائدة التي تعود على الأم تفوق المخاطر المحتملة للجنین. لا ترضعي أثناء إستخدام یونیبروست&reg;.</p><p>&nbsp;</p><p>القیادة وإستخدام الآلات</p><p>ًیونیبروست&reg; قد یسبب أحیانادوخة أو إغماء.في مثل ھذا الحدثیجب توخي الحذر خلال ,الأنشطة التي تتطلب الإنتباه، مثل القیادة، وتشغیل الآلات والعمل فى الأماكن المرتفعة. إذا كنت غیر متأكد أن یونیبروست&reg; لھ تأثیر سلبي على قدرتك على القیادة، یجب مناقشة ھذا الأمر مع الطبیب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>الجرعة المعتادة ھي:</p><p>ضغط دم مرتفع: الجرعة الأولیة ھي ا مج يوميا في جرعة واحدة, بعد&nbsp;۱- ۲ اسابيع, يتم زيادة الجرعة إلى&nbsp; ۲ مج في جرعة يومية واحدة(24 ساعة).&nbsp;یتم الاحتفاظ بھذه الجرعة أیضا&nbsp;لمدة ۲-۱ أسابيع. إذا لزم لأمر&nbsp;&nbsp;یمكن زیادة الجرعة إلى 4&nbsp;، ۸ أو ۱٦ مج یومیا حتى يتم تحقيق&nbsp;الحد المطلوب في ضغط الدم.لجرعة الیومیة القصوى ھي ۱٦ مج. ویفضل أن تؤخذ الجرعة الأولیة قبل النوم. وھذا یعني أن أي دوار قد تواجھ ھو مشكلة بسیطة.</p><p>بروستاتا متضخمة:&nbsp;الجرعة الأولیة ھي ۱ مج یومیا (24 ساعة) في جرعة واحدة. بعد هذه الجرعة&nbsp;المعتادة ھي ۲ مج أو 4 مج يوميا.&nbsp;في بعض الظروف یمكن زیادة ھذا إلى حد أقصى قدره 8 مج يوميا.</p><p>&nbsp;</p><p>يجب أن تؤخذ أقراص یونیبروست&reg; كجرعة واحدة كل یوم(۲٤ ساعة) . يجب أن تؤخذ أقراص یونیبروست&reg; مع الكثیر من الماء.&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>إذا تناولت یونیبروست&reg; أكثر مما ینبغي.</p><p>إذا تناولت أكثر من الجرعة الموصوفة، یجب علیك إستشارة طبیبك و/ أو الصیدلي فورا. إذا كنت&nbsp;تشعر بالدوار الشدید أو تعتقد أنك قد یغمى علیك، یجب&nbsp;أن تستلقي مباشرة وتكون رأسك لأسفل.</p><p>&nbsp;</p><p>إذا توقفت عن تناول یونیبروست&reg;</p><p>&nbsp;</p><p>إذا توقفت فجأه عن تناول یونیبروست&reg; فالأعراض التي عانیت منھا قبل بدء العلاج قد تتكرر.&nbsp;</p><p>.ًولذلك فمن الأفضل أن لا تتوقف عن تناول ھذا الدواء فجأة. طبیبك سوف یقلل الجرعة تدریجی</p><p>یجب علیك إستشارة طبیبك أو الصیدلي إذا كنت غیر متأكد دائمًا.&nbsp;</p><p>إذا كان لدیك أي أسئلة أخرى عن استخدام ھذا الدواء، إسأل طبیبك أو الصیدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كل الأدویة، یونیبروست&reg; یمكن أن یسبب آثار جانبیة.</p><p>بعض الآثار الجانبیة یمكن أن تكون خطیرة. إذا حدث أي مما یلي، توقف عن تناول ھذا الدواء وأخبر طبیبك فورا أو انتقل إلى قسم الإصابات في أقرب مستشفى:</p><p>الحساسیة مثل ألزیز، وضیق في التنفس، والدوخة الشدیدة أو االنھیار، وتورم الوجھ أو الحلق، أو طفح جلدي خطیر مع بقع حمراء أو بثور.</p><p>&nbsp;</p><p>- ألم في الصدر، وزیادة أو عدم انتظام ضربات القلب، والنوبات القلبیة أو السكتة الدماغیة.</p><p>- اصفرار الجلد أو بیاض العینین، والناجمة عن مشاكل في الكبد.</p><p>- كدمات غیر عادیة أو نزیف ناجم عن انخفاض الصفائح الدمویة.</p><p>&nbsp;</p><p>ھذه الآثار الجانبیة غیر شائعة (تؤثر على ۱ إلى ۱۰ مستخدم في ۱، ۰۰۰)&nbsp;أو نادرة (تؤثر على 1 إلى ۱۰ مستخدمین في ۱۰،۰۰۰)&nbsp;</p><p>&nbsp;</p><p>الآثار الجانبیة الأخرى:</p><p>شائع جدًا (یؤثر على أكثر من 1 مستخدم في 10):</p><p>- الشعور بالدوار، صداع الراس.</p><p>مشترك (يؤثر على 1 إلى 10 مستخدمين في 100):</p><p>- التھاب الممرات الھوائیة داخل الرئتین، السعال، نقص في التنفس، حساسیة الأنف، سیلان الأنف أو عدوى الجھاز التنفسي.</p><p>التھاب المسالك البولیة، سلس البول )عدم القدرة على السیطرة على مرور البول( - فقدان الشهية.&nbsp;</p><p>- القلق، الأرق، والعصبیة.</p><p>- الشعور بالدوار، وخز أو خدر في الیدین والقدمین ، والنعاس.</p><p>الشعور أو الإحساس بعدم انتظام ضربات القلب )خفقان(، وزیادة معدل ضربات القلب</p><p>-&nbsp;&nbsp;انخفاض ضغط الدم نتیجة للنھوض من وضع الجلوس أو انخفاض ضغط الدم الوضعي.</p><p>&nbsp;</p><p>- آلام في البطن، وعسر الھضم، وجفاف الفم، والشعور الغثیان، والإسھال</p><p>- الحكة</p><p>- آلام الظھر، آلام في العضلات</p><p>- التھاب المثانة</p><p>- الشعور بالضعف )الوھن(، وآلام في الصدر، وأعراض الأنفلونزا</p><p>- تورم في الكاحلین والقدمین أو الأصابع ، والشعور بالتعب ، والشعور بالضیق.</p><p>&nbsp;</p><p>غیر شائع یؤثر على( ۱ إلى ۱۰ مستخدمین في ۱۰۰۰):</p><p>- رد الفعل التحسسي.</p><p>- النقرس، وزیادة الشھیة.</p><p>- الإثارة والاكتئاب.</p><p>- السكتة الدماغیة، وانخفاض شعور اللمس أو الإحساس، والإغماء.</p><p>- رنین أو ضجیج في الأذنین (طنین).</p><p>-&nbsp;ألم في الصدر )الذبحة الصدریة(، والنوبات القلبیة ، وعدم انتظام ضربات القلب</p><p>- تدفق مائي.</p><p>- نزیف في الأنف والسعال.</p><p>الإمساك، وانتفاخ البطن، والتقیؤ ، والتھاب الجھاز الھضمي.</p><p>- اختبار وظائف الكبد یظھر نتائج غیر طبیعیة.</p><p>- الطفح الجلدي، وفقدان الشعر )ثعلبة(، والطفح الجلدي الناجم عن النزیف تحت الجلد.</p><p>- آلام المفاصل، وتشنجات العضلات، وضعف العضلات.</p><p>التبول المؤلم أو الصعب، وجود خلایا الدم الحمراء في البول ، سلس البول )عدم القدرة على السیطرة على مرور البول).</p><p>&nbsp;</p><p>نادر جدًا: (یؤثر على أقل من مستخدم واحد في 10000 )</p><p>- انخفاض أعداد الصفائح الدمویة، انخفاض عدد خلایا الدم البیضاء والحمراء</p><p>- رؤیة غیر واضحة</p><p>- انخفاض معدل ضربات القلب</p><p>- تشنج القصبي</p><p>- منع تدفق الصفراء )ركود صفراوي(، التھاب الكبد.</p><p>- اصفرار الجلد أو بیاض العینین الناجمة عن مشاكل الكبد أو الدم (الیرقان).</p><p>- اختبارات وظائف الكبد تظھر نتائج غیر طبیعیة.&nbsp;</p><p>- زیادة مستویات الدم من الیوریا والكریاتین.</p><p>عرقلة التدفق الطبیعي للصفراء )تشولستاتیس( الذي قد یسبب الیرقان )اصفرار الجلد أو بیاض العینین).</p><p>- خلایا النحل (الشرى).</p><p>- اضطراب في تمریر البول، وتحتاج إلى تمریر البول لیلا، وزیادة حجم البول مرت توسیع مؤقت من الثدیین (جینیكوماستیا)، والانتصاب المستمر المؤلم غیر معروف (لا یمكن تقدیر التردد من البیانات المتاحة).</p><p>- قد تحدث مشاکل في العین أثناء جراحة العین من أجل إعتام عدسة العین (غمامة).</p><p>- تشوھات في حاسة التذوق.</p><p>- قلة أو إنعدام السائل المنوي في القذف في ذروة الجنسیة</p><p>إذا كان أي من اآلثار الجانبیة خطیر، أو إذا لاحظت أي آثار جانبیة غیر مدرجة في ھذه النشر&nbsp;یرجى إخبار الطبیب أو الصیدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- یحفظ في درجة حرارة لا تزید عن ۳۰ م&deg;&nbsp;</p><p>- احفظه&nbsp;بعیدا عن متناول الأطفال.&nbsp;</p><p>- لا تستخدم یونیبروست&reg; أقراص بعد تاریخ انتھاء الصلاحیة المذكور على العلبة والشریط . تاریخ إنتھاء الصلاحیة یشیر إلى الیوم الأخیر فى ذلك الشھر بعد كلمة . EXP</p><p>وینبغي أن لا یتم التخلص من الأدویة عن طریق میاه الصرف الصحي أو النفایات المنزلیة. اسأل الصیدلي حول كیفیة التخلص من الأدویة التي لم تعد مطلوبة. وستساعد ھذه التدابیر على حمایة&nbsp;البیئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة ھي: دوكسازوسین )على ھیئة میسیلات(.یحتوي كل قرص محزز من یونیبروست&reg; على 4&nbsp;ملجم دوكسازوسین (على ھیئة میسیلات).</p><p>المكونات الأخرى ھي: لاكتوز أحادي الھیدرات، بوفیدون، متعدد السوربات ۰ ۸ ،ستیرات</p><p>الماغنسیوم، كریستالات السیلیلوز الدقیقة، جلیكولات نشا الصودیوم، ثاني أكسید السیلیكون&nbsp;الغروى، كحول أیزوبروبیلى. &nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص یونیبروست&reg; بیضاء مستدیرة ثنائیة التحدب وغیر مغلفة.</p><p>یتوفر یونیبروست &reg; أقراص في عبوة كرتون تحتوي على ۲۰ قرصا شرائط مع النشرة ً &nbsp;الداخلیة للمریض.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>بترجي فارما</p><p>الشارع رقم ٤۰۱ ،شارع رقم ٤۰۳ ،</p><p>منطقة المرحلة الرابعة الصناعیة،</p><p>ص. مربع: ۱۰٦٦۷ ،</p><p>جدة ۲۱٤٤۳ ،</p><p>المملكة العربیة السعودیة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05/2014
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                UNIPROST® 4 mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each cross scored tablet contains 4 mg of Doxazosin (as mesylate).
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets.
White round biconvex uncoated tablets with one side lip type cross scored and side BP13.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Essential hypertension. Doxazosin is not appropriate for first-line treatment. It may be used as a monotherapy in patients who have failed to respond to or have contraindications to other agents. Alternatively, use should be limited to second or third line treatment in combination with other antihypertensives.<br />&bull; Symptomatic treatment of benign prostatic hyperplasia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>treatment should be established by a physician. Hypertension:<br />Doxazosin is used in a once daily regimen: the initial dose is 1mg, to minimise the potential for postural hypotension and/or syncope (see section 4.4). Dosage may then be increased to 2mg after an additional one or two weeks of therapy and thereafter, if necessary to 4mg. The majority of patients who respond to Doxazosin will do so at a dose of 4mg or less. Dosage can be further increased if necessary to 8mg or the maximum recommended dose of 16mg. Benign Prostatic Hyperplasia:<br />The recommended initial dosage of Doxazosin is 1mg given once daily to minimise the potential for postural hypotension and/or syncope (see section 4.4). Depending on the individual patient&#39;s urodynamics and BPH symptomatology dosage may then be increased to 2mg and thereafter to 4mg and up to the maximum recommended dose of 8mg. The recommended titration interval is 1-2 weeks. The usual recommended dose is 2-4mg daily.</p><p>Use in elderly:<br />Same dosage as for adults.<br />Use in patients with renal impairment:<br />There is no change in pharmacokinetics of doxazosin in patients with renal impairment. Therefore, the usual dose is generally recommended. Due to possible hypersensitivity in some of these patients, it may be necessary to take special care at the beginning of treatment. Doxazosin is not dialysable due to the fact that it is highly protein-bound.<br />Use in patients with hepatic impairment:<br />The dosage should be increased with special care in patients with hepatic impairment. There is no clinical experience with patients with severe hepatic impairment (see section 4.4).<br />Paediatric population:<br />&#39;The safety and efficacy of Doxazosin in children and adolescents have not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                UNIPROST® is contraindicated in:
• Patients with a known hypersensitivity to quinazolines (e.g. prazosin, terazosin, doxazosin), or any of the excipients.
• Patients with a history of orthostatic hypotension.
• Patients with benign prostatic hyperplasia and concomitant congestion of the upper urinary tract, chronic urinary tract infection or bladder stones
• During lactation.
• Patients with hypotension.
• As monotherapy in patients with either overflow bladder or anuria with or without progressive renal insufficiency.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Initiation of therapy:<br />In relation with the alpha blocking properties of doxazosin, patients may experience postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness (syncope), particularly with the commencement of therapy. Therefore, it is prudent medical practice to monitor blood pressure on initiation of therapy to minimize the potential for postural effects. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of doxazosin therapy.<br />Use in patients with acute cardiac conditions:<br />As with other vasodilatory antihypertensive agent it is prudent medical practice to advise caution when administering doxazosin to patients with following cardiac conditions:</p><p>- Pulmonary oedema due to aortic or mitral stenosis.<br />- Heart failure at high output.<br />- Right-sided heart failure due to pulmonary embolism or pericardial effusion.<br />- Left ventricular heart failure with low filling pressure.<br />Use in hepatically impaired patients:<br />As with any drug wholly metabolized by the liver, doxazosin should be administered with particular caution to patients with evidence of impaired hepatic function. Since there is no clinical experience in patients with severe hepatic impairment use in these patients is not recommended.<br />Use with PDE5 inhibitors:<br />Concomitant administration of doxazosin with phosphodiesterase 5 inhibitors (e.g. sildenafil, tadalafil, and vardenafil) should be done with caution as both drugs have vasodilating effects and may lead to symptomatic hypotension in some patients. To reduce the risk of orthostatic hypotension it is recommended to initiate the treatment with phosphodiesterase 5 inhibitors only if the patient is hemodynamically stabilized on alpha blocker therapy. Furthermore, it is recommended to initiate phosphodiesterase 5 inhibitor treatment with the lowest possible dose and to respect a 6 hour time interval from intake of doxazosin.<br />Use in patients undergoing cataract surgery:<br />The &#39;Intraoperative Floppy Iris Syndrome&#39; (IFIS, a variant of small pupil syndrome) has been observed during cataract surgery in some patients on or previously treated with tamsulosin. Isolated reports have also been received with other alpha1 blockers and the possibility of a class effect cannot be excluded. As IFIS may lead to increased procedural complications during the cataract operation current or past use of alpha1 blockers should be made known to the ophthalmic surgeon in advance of surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Concomitant administration of doxazosin with phosphodiesterase-5-inhibitors (eg. sildenafil, tadalafil, vardenafil) may lead to symptomatic hypotension in some patients.<br />&bull; Doxazosin is highly bound to plasma proteins (98%). In vitro data in human plasma indicates that doxazosin has no effect on protein binding of the drugs tested (digoxin, phenytoin, warfarin or indometacin).<br />&bull; Conventional doxazosin has been administered without any adverse drug interaction in clinical experience with thiazide diuretics, furosemide, beta-blocking agents, non-steroidal anti-inflammatory drugs, antibiotics, oral hypoglycaemic drugs, uricosuric agents, or anticoagulants. However, data from formal drug/drug interaction studies are not present.</p><p>&bull; Doxazosin potentiates the blood pressure lowering activity of other alpha-blockers and other antihypertensives.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use during pregnancy:<br />As there are no adequate and well controlled studies in pregnant women, the safety of doxazosin during pregnancy has not been established. Accordingly, during pregnancy, doxazosin should be used only if the potential benefit outweighs the risk. Although no teratogenic effects were seen in animal testing, reduced foetal survival was observed in animals at high doses.<br />Use during lactation:<br />Doxazosin is contraindicated during lactation as the drug accumulates in milk of lactating rats and there is no information about the excretion of the drug into the milk of lactating women. Alternatively, mothers should stop breastfeeding when treatment with doxazosin is necessary</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The ability to engage in activities such as operating machinery or operating a motor vehicle may be impaired, especially when initiating therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequencies used are as follows: very common (&ge; 1/10), common (&ge; 1/100 to &lt;1/10), uncommon (&ge; 1/1,000 to &lt;1/100), rare (&ge; 1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), not known (cannot be estimated from the available data).</p><p>Common:&nbsp;Respiratory tract infection, urinary tract infection</p><p>Very Rare:&nbsp;Leukopenia, thrombocytopenia</p><p>Uncommon:&nbsp;Allergic drug reaction</p><p>Common:&nbsp;Anorexia</p><p>Uncommon:&nbsp;gout, increased appetite</p><p>Common:&nbsp;Anxiety, insomnia, nervousness</p><p>Uncommon:&nbsp;Agitation, depression</p><p>Very common:&nbsp;Dizziness, headache</p><p>Common:&nbsp;Dizziness postural, paresthesia, somnolence</p><p>Uncommon:Cerebrovascular accident, hypoesthesia, syncope, tremor</p><p>Very Rare:Blurred vision</p><p>Unknown:Introperative floppy iris syndrome (see Section 4.4)</p><p>Common:Vertigo</p><p>Uncommon:Tinnitus</p><p>Common:Palpitation, tachycardia</p><p>Uncommon:Angina pectoris, myocardial infarction, cardiac arrhythmias</p><p>Very Rare:Bradycardia</p><p>Common:Hypotension, postural hypotension</p><p>Uncommon:Hot flushes</p><p>Common:Bronchitis, cough, dyspnea, rhinitis</p><p>Uncommon:Epistaxis, cough</p><p>Very Rare:Bronchospasm aggravated</p><p>Common:Abdominal pain, dyspepsia, dry mouth, nausea, diarrhoea<br />Uncommon:Constipation, flatulence, vomiting, gastroenteritis<br />Unknown:Taste disturbances<br /><br />Uncommon:Abnormal liver function tests<br />Very Rare:Cholestasis, hepatitis, jaundice, abnormal liver function tests<br /><br />Common:Pruritus<br />Uncommon:Skin rash, alopecia, purpura<br />Very Rare:urticaria<br />Common:Back pain, myalgia<br />Uncommon:Arthralgia, muscle cramps, muscle weakness<br /><br />Common:Cystitis, urinary incontinence<br />Uncommon:Dysuria, micturition frequency, hematuria, polyuria, urinary incontinence<br />Very Rare:Increased diuresis, micturition disorder, nocturia<br /><br />Uncommon:Impotence<br />Very Rare:Gynecomastia, priapism<br />Unknown:Retrograde ejaculation</p><p><br />Common:Asthenia, chest pain, influenza-like symptoms, peripheral oedema, fatigue, malaise<br />Uncommon: Pain, facial oedema</p><p>Uncommon:Weight increase</p><p><br />- To report any side effect(s) in Saudi Arabia;<br />- National Pharmacovigilance Center (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222 Exts: 2317- 2356- 2353- 2354- 2334- 2340.<br />&bull; Toll- free number: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Should over dosage lead to hypotension, the patient should be immediately placed in a supine, head down position.<br />Other supportive measures should be performed if thought appropriate in individual cases. Since doxazosin is highly protein bound, dialysis is not indicated.<br />If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressor should then be used. Renal function should be monitored and supported as needed.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Alpha-adrenoceptor antagonists.<br />ATC code: C02CA04<br />Doxazosin is a selective and competitive antagonist of postsynaptic alpha1adrenergic receptors.<br />The administration of doxazosin causes a significant reduction in blood pressure due to decreased pheripheral vascular resistance. One daily dosage results in a clinically significant reduction in blood pressure, which will continue for 24 hours. After administration, a gradual reduction in blood pressure occurs; orthostatic effects at the start of treatment may occur. The largest decrease in blood pressure is obtained approximately 2 to 6 hours after administration.<br />During treatment with doxazosin, regression of left ventricle hypertrophy has been reported.<br />Contrary to the nonselective alpha-adrenergicreceptor blocking substances, no tolerance has been observed during long term treatment with doxazosin.</p><p>Clinical studies have demonstrated that doxazosin causes a small decrease in triglyceride plasma concentrations, total cholesterol and LDL fraction. A small increase in HDL/total cholesterol ratio has been observed (approximately 4 to 13% of the initial value). The clinical relevance of these results has to be established. Doxazosin increases sensitivity to insulin in patients with alteration of glucidic metabolism.<br />Administration of doxazosin to patients with symptomatic BPH results in an improvement of urodynamic complaints. Studies have shown that this effect results from selective blockade of the alpha-adrenoreceptors in the smooth muscles of the bladder neck, the bladder, the capsule of the prostate and the urethra.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Following oral administration, doxazosin is well absorbed. The peak plasma levels are achieved after 2 hours, and the absolute bioavailability is approximately 63%. Doxazosin is highly protein bound in plasma (approximately 98%). The plasma elimination occurs in two phases. The terminal half-life is 16-30 hours thus making the drug suitable for once daily administration. Doxazosin is predominantly metabolized by the liver and is mainly excreted by the faeces (63-65%) ; less than 5% of the dose is excreted as unchanged doxazosin. 6-Hydroxy-doxazosin is a strong and selective alpha-adrenergic receptor blocking substance and in humans 5% of the oral dose is metabolized in this substance.<br />Pharmacokinetic studies in elderly and patients with renal insufficiency did not show significant pharmacokinetic differences compared to patients with a normal renal function. There are only limited data concerning the use of doxazosin in patients with liver impairment and concerning the effects of drugs known to influence hepatic metabolism (e.g. cimetidine). In a clinical study in 12 patients with mild hepatic insufficiency, single oral dose administration of doxazosin resulted in an increase in the area under the concentration-time-curve (AUC) of 43% and a decrease in clearance of 40%.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nonclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenicity and gastrointestinal tolerance. Studies in pregnant rabbits and rats at daily doses resulting in plasma concentrations 4 and 10 times the human exposure (Cmax and AUC), respectively, revealed no evidence of harm to the fetus. A dosage regimen of 82 mg/kg/day (8 times the human exposure) was associated with reduced fetal survival.</p><p>A male fertility study performed in the rat revealed that doxazosin can adversely affect fertility and reproductive performance. Alpha-adrenergic blocking agents may inhibit labour in rats.<br />Studies in lactating rats given a single oral dose of radioactive doxazosin gave an accumulation in the breast milk with a maximum concentration of about 20 times greater than the maternal plasma concentration. Radioactivity was found to cross the placenta following oral administration of labeled doxazosin to pregnant rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Lactose monohydrate<br />&bull; Povidone<br />&bull; Polysorbate 80<br />&bull; Magnesium stearate<br />&bull; Microcrystalline cellulose<br />&bull; Colloidal silicon dioxide<br />&bull; Sodium starch glycolate<br />&bull; Isopropyl alcohol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at temperature not exceeding 30&ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carton box containing 20 tablets in blisters along with a patient information leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BATTERJEE PHARMA
Jeddah Industrial City
Jeddah-KSA
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10-May-17
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>